Targeted protein degradation by KLHDC2 ligands identified by high-throughput screening
Proteolysis-targeting chimeras (PROTACs) enable the selective and sub-stoichiometric elimination of pathological proteins, yet only two E3 ligases are routinely used for this purpose. Here, we expand the repertoire of PROTAC-compatible E3 ligases by identifying a novel small molecule scaffold target...
Saved in:
| Main Authors: | Han Zhou, Tonglian Zhou, Wenli Yu, Liping Liu, Yeonjin Ko, Kristen A Johnson, Ian A Wilson, Peter G Schultz, Michael J Bollong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
eLife Sciences Publications Ltd
2025-06-01
|
| Series: | eLife |
| Subjects: | |
| Online Access: | https://elifesciences.org/articles/106844 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unraveling the Engagement of Kinases to CRBN Through a Shared Structural Motif to Optimize PROTACs Efficacy
by: Serena Rosignoli, et al.
Published: (2025-02-01) -
Ubiquitination of transcription factors in cancer: unveiling therapeutic potential
by: Dongha Kim, et al.
Published: (2025-08-01) -
Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities
by: Aiman B. Awan, et al.
Published: (2025-01-01) -
PROTAC<sup>®</sup> technology and potential for its application in infection control
by: M. A. Zakharova, et al.
Published: (2024-07-01) -
Unraveling chain specific ubiquitination in cells using tandem ubiquitin binding entities
by: Muhammad Shahzad Ali, et al.
Published: (2025-07-01)